<ARTICLE> 5
<MULTIPLIER> 1,000
       
                             
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                         DEC-31-1999
<PERIOD-START>                            JAN-01-1999
<PERIOD-END>                              MAR-31-1999
<CASH>                                      2,404,441
<SECURITIES>                                   46,085         
<RECEIVABLES>                               1,522,076
<ALLOWANCES>                                   56,507
<INVENTORY>                                   929,817
<CURRENT-ASSETS>                            5,700,505 
<PP&E>                                      7,036,177
<DEPRECIATION>                              3,183,385
<TOTAL-ASSETS>                             11,225,650
<CURRENT-LIABILITIES>                       3,118,960
<BONDS>                                     1,982,188
<PREFERRED-MANDATORY>                               0
<PREFERRED>                                         0
<COMMON>                                      688,267
<OTHER-SE>                                  4,171,740
<TOTAL-LIABILITY-AND-EQUITY>               11,225,650
<SALES>                                     2,255,572 
<TOTAL-REVENUES>                            2,255,572
<CGS>                                         493,549         
<TOTAL-COSTS>                                 493,549 
<OTHER-EXPENSES>                            1,067,351<F1>
<LOSS-PROVISION>                                    0<F2>
<INTEREST-EXPENSE>                             43,871
<INCOME-PRETAX>                               543,502
<INCOME-TAX>                                   92,100
<INCOME-CONTINUING>                           451,402
<DISCONTINUED>                                174,296 
<EXTRAORDINARY>                                     0
<CHANGES>                                           0 
<NET-INCOME>                                  625,698
<EPS-PRIMARY>                                     .57
<EPS-DILUTED>                                     .56
<FN>
<F1> Amounts include research and development, marketing and administrative 
     expenses, and asset impairment charge.
<F2> The information called for is not given as the balances are not 
     individually significant.
</FN>